Atlas Trials

Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects

Clinical trial NCT02660736 · COMPLETED

Trial details

NCT number
NCT02660736
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2016-02-01
Primary completion
2016-08-01
Enrollment
59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.